Related Experiment Video
Updated: Aug 8, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Unusual complications after bone marrow transplantation for dyskeratosis congenita
1Bone Marrow Transplant Unit, Hospital Saint Louis, Paris, France.
Abstract:
Dyskeratosis congenita (DC) is a rare inherited disorder often associated with aplastic anaemia. We report the cases of five boys transplanted with an HLA-identical related donor for severe aplastic anaemia (SAA) associated to DC; in all cases successful engraftment was observed. Three patients died 2-8 years after bone marrow transplantation (BMT) with signs of endothelial cell damage syndrome (kidney microangiopathy and liver veno-occlusive disease). Another boy died 1 year after BMT from Evans syndrome and invasive aspergillosis. One boy currently presents anaemia, polyarthritis of unknown origin, pulmonary fibrosis and gut malabsorption 7.5 years after BMT. SAA associated with DC can be successfully treated by allogeneic BMT. However, these early and late complications observed are very unusual after BMT and probably reflect the association of transplanted-related factors, evolution of the underlying disease, and increased sensitivity of endothelial cells. Modified conditioning approaches, advances in supportive care and surveillance of these unusual complications offer the possibility of improved outcome for these patients.
Insights
Dyskeratosis congenita (DC) with severe aplastic anemia (SAA) can be treated with bone marrow transplantation (BMT). However, patients face unusual early and late complications, necessitating modified approaches for better outcomes.
Area of Science:
- Hematology
- Genetics
- Oncology
Background:
- Dyskeratosis congenita (DC) is a rare inherited disorder.
- DC is often associated with severe aplastic anemia (SAA).
Observation:
- Five boys with DC and SAA underwent HLA-identical related donor bone marrow transplantation (BMT).
- Successful engraftment was observed in all patients.
- Three patients died 2-8 years post-BMT due to endothelial cell damage syndrome.
- One patient died 1 year post-BMT from Evans syndrome and invasive aspergillosis.
- One patient developed anemia, polyarthritis, pulmonary fibrosis, and malabsorption 7.5 years post-BMT.
Findings:
- Allogeneic BMT can successfully treat SAA associated with DC.
- Unusual early and late complications were observed post-BMT.
- Complications may stem from transplant factors, disease evolution, and endothelial cell sensitivity.
Implications:
- Modified conditioning regimens and supportive care are crucial.
- Surveillance for unusual complications can improve patient outcomes.
- Further research into endothelial cell sensitivity in DC patients is warranted.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Healing II: Complications

